基本信息
浏览量:2
职业迁徙
个人简介
Description of Research Expertise
Human Cancer Immunology is the focus of our laboratory and clinical efforts.
The development of a systematic approach to identify and validate cancer neoantigens is a primary interest of our research laboratory. In collaboration with experts in cancer genomics, we have created a bioinformatics pipeline to identify tumor-specific missense mutations which encode neoantigenic peptides. Our team has successfully applied this strategy to develop the first test of personalized cancer vaccination in humans with melanoma. Ongoing proof-of-concept trials aim to test neoantigens as targets for various immunotherapy strategies in melanoma and other solid tumors. In particular, our work aims to characterize the functional and phenotypic landscape of vaccine-elicited T cells using molecular technologies.
A related interest is the development of cellular therapies for cancer. We are currently exploring the development of neoantigen-specific T cell therapy for use in patients. We work collaboratively with research groups in order to find novel solutions to overcome the inherent obstacles created by the tumor microenvironment. The long term goal is to advance and test personalized medicine based approaches in cancer patients.
Human Cancer Immunology is the focus of our laboratory and clinical efforts.
The development of a systematic approach to identify and validate cancer neoantigens is a primary interest of our research laboratory. In collaboration with experts in cancer genomics, we have created a bioinformatics pipeline to identify tumor-specific missense mutations which encode neoantigenic peptides. Our team has successfully applied this strategy to develop the first test of personalized cancer vaccination in humans with melanoma. Ongoing proof-of-concept trials aim to test neoantigens as targets for various immunotherapy strategies in melanoma and other solid tumors. In particular, our work aims to characterize the functional and phenotypic landscape of vaccine-elicited T cells using molecular technologies.
A related interest is the development of cellular therapies for cancer. We are currently exploring the development of neoantigen-specific T cell therapy for use in patients. We work collaboratively with research groups in order to find novel solutions to overcome the inherent obstacles created by the tumor microenvironment. The long term goal is to advance and test personalized medicine based approaches in cancer patients.
研究兴趣
论文共 57 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Adham S. Bear, Rebecca B. Nadler,John Scholler,Robert H. Vonderheide,Gerald P. Linette,Beatriz M. Carreño
Molecular Cancer Researchno. 5_Supplement (2023): PR08-PR08
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
BLOOD (2023): 102
Paula M Fracasso,Sherry A Goodner,Jonathan D Wildi,Michael J Naughton,Gerald P Linette,Ramaswamy Govindan,Benjamin R Tan,Kristie A Blum,Gary J Jones, Tillman E Pearce, Daniel J Levitt,Gerald H Clamon
Clinical Cancer Researchno. 6 (2022): 1098-1106
引用0浏览0引用
0
0
Adham S. Bear, Rebecca B. Nadler,John Scholler,Robert H. Vonderheide,Gerald P. Linette,Beatriz M. Carreno
Cancer Researchno. 22_Supplement (2022)
引用0浏览0引用
0
0
Regular and Young Investigator Award Abstracts (2022): A324-A324
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn